BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24559441)

  • 1. Induction chemotherapy in head and neck cancer: are we too ambitious?
    Specenier P
    Future Oncol; 2014 Feb; 10(3):337-40. PubMed ID: 24559441
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of induction chemotherapy for head and neck squamous cell carcinoma.
    Haigentz M; Cohen EE; Wolf GT; Strojan P; Eisbruch A; Ferlito A
    Oral Oncol; 2012 Nov; 48(11):1065-7. PubMed ID: 22981388
    [No Abstract]   [Full Text] [Related]  

  • 3. Second-line chemotherapy in head and neck cancer: what should we expect?
    Büntzel J; Micke O
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

  • 6. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
    Lamont EB; Vokes EE
    Lancet Oncol; 2001 May; 2(5):261-9. PubMed ID: 11905780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials.
    Browman GP; Cronin L
    Semin Oncol; 1994 Jun; 21(3):311-9. PubMed ID: 7516093
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
    Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
    Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction chemotherapy in squamous cell carcinoma of the head and neck: saved by the bell?
    Specenier P
    Oral Oncol; 2015 Feb; 51(2):e5-7. PubMed ID: 25497106
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction and adjuvant chemotherapy for head and neck cancer: future perspectives.
    Forastiere AA
    Acta Otorhinolaryngol Belg; 1999; 53(3):277-80. PubMed ID: 10635408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab in squamous cell carcinoma of the head and neck.
    Hitt R; Martín P; Hidalgo M
    Future Oncol; 2006 Aug; 2(4):449-57. PubMed ID: 16922611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of head and neck cancer.
    Alberts DS; Coulthard SW
    Ariz Med; 1977 Oct; 34(10):695-7. PubMed ID: 931664
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction chemotherapy in head and neck cancer.
    Hitt R
    Ann Oncol; 2006 Sep; 17 Suppl 10():x42-4. PubMed ID: 17018749
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
    Ferguson PJ
    J Otolaryngol; 1995 Aug; 24(4):242-52. PubMed ID: 8551538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy of head and neck cancer: most effective agents, areas of promise.
    Urba SG; Forastiere AA
    Oncology (Williston Park); 1989 Apr; 3(4):79-88; discussion 88, 90, 97-8. PubMed ID: 2701419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.